White collar crime: Does India need to do a China to curb bribery?
This article was originally published in Scrip
More than a decade ago, Scrip reported how an Indian firm, now part of a large multinational group, blatantly offered exquisite holidays against more prescriptions of its product [Scrip Magazine December 2002: Currying favour in India]. The firm even specified how many additional orders, vials in this case, would be needed to take the kids along and also facilitated instalment purchases!
You may also be interested in...
Also, deals involving Sumitomo Dainippon, Tolero, Boston Biomedical, Zai Lab, Turning Point, SciClone, EpicentRx, Yuhan, GI Innovation, Takeda, Carmine, HitGen, Morphic, CStone and Burning Rock.
India clears Opdivo patent, turning down pre-grant representations from four opposing parties including Dr Reddy's. The patent office rejected the opponents' arguments including those around obviousness and "inherent anticipation."
Private equity group Carlyle has acquired 20% of Piramal's pharma business for close to $500m, with the Indian group expected to use the capital raise to bolster organic and inorganic growth and deleverage the balance sheet.